Verified ComparisonLast updated: 10 April 2026
SS-31 vs MOTS-c
SS-31 (elamipretide) targets inner mitochondrial membrane. MOTS-c (mitochondrial open reading frame of the 12S rRNA-c) acts on cellular signaling. Different targets.
SS-31 / Elamipretide
Longevity
4.4/ 5
A
MOTS-c
Longevity
4.2/ 5
A−
Editor's note
SS-31 focuses on cardiac and neuroprotection; MOTS-c on metabolic and exercise mimicry.
| Criterion | SS-31 / Elamipretide | MOTS-c |
|---|---|---|
| Mitochondrial target | Inner membrane (cardiolipin) | Signaling pathway (AMP-K) |
| Cardiac research depth | Extensive | Growing |
| Metabolic/exercise research | Growing | Primary focus |
| Neuroprotection data | Substantial | Emerging |
| Clinical trial advancement | Phase II/III (cardiac) | Early stages |
Frequently asked questions
SS-31 has more clinical data; MOTS-c is emerging in metabolic research.
Want to read the full reviews?